Regulation of activin A synthesis in microglial cells: Pathophysiological implications for bacterial meningitis

Journal of Neuroscience Research

Volumn 88, Issue 1, 2010, Pages 16-23

  Wilms, Henrik ^a   Schwark, Thorsten ^b   Brandenburg, Lars Ove ^b   Sievers, Jobst ^b   Dengler, Reinhard ^c   Deuschl, Günther ^b   Lucius, Ralph ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Activin A; Cerebrospinal fluid; ELISA; Meningitis; Microglia; RT PCR

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR 2; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALPHA CHAIN; ANIMAL CELL; ARTICLE; BACTERIAL MENINGITIS; BETA CHAIN; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MEDIATOR; MICROGLIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL; VIRUS MENINGITIS; WESTERN BLOTTING;

ACTIVIN RECEPTORS; ACTIVINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MALE; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; MICROGLIA; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 73949148927     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22185     Document Type: Article

References (31)

1. Beckman JS, Koppenol WH. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437.
2. Bermpohl D, Halle A, Freyer D, Dagand E, Braun JS, Bechmann I, Schroder NW, Weber JR. 2005. Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest 115:1607-1615.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL, Tuomanen EI. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 5:298-302.
5. 2 mediate brain cell apoptosis during meningitis. J Clin Invest 109:19-27.
6. De Groot CJ, Montagne L, Barten AD, Sminia P, Van Der Valk P. 1999. Expression of transforming growth factor (TGF)-β1, -β2, and -β3 isoforms and TGF-β type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J Neuropathol Exp Neurol 58:174-187.
7. Ebert S, Phillips DJ, Jenzewski P, Nau R, O'Connor AE, Michel U. 2006. Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis. J Neurol Sci 250:50-57.
8. Ebert S, Zeretzke M, Nau R, Michel U. 2007. Microglial cells and peritoneal macrophages release activin A upon stimulation with Toll-like receptor agonists. Neurosci Lett 413:241-244.
9. Gebicke-Haerter PJ, Bauer J, Schobert A, Northoff H. 1989. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci 9:183-194.
10. Giegerich R, Meyer F, Schleiermacher C. 1996. GeneFisher-software for the detection of postulated genes. Proc Int Conf Intell Syst Mol Biol 4:68-77.
11. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178.
12. Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. 2000. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 83:111-116.
13. Gutteridge JM. 1995. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41:1819-1828.
14. Hashimoto M, Kondo S, Sakurai T, Etoh Y, Shibai H, Muramatsu M. 1990. Activin/EDF as an inhibitor of neural differentiation. Biochem Biophys Res Commun 173:193-200.
15. Hubner G, Brauchle M, Gregor M, Werner S. 1997. Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab Invest 77:311-318.
16. Hughes PE, Alexi T, Williams CE, Clark RG, Gluckman PD. 1999. Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 92:197-209.
17. Iwahori Y, Saito H, Torii K, Nishiyama N. 1997. Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res 760:52-58.
18. Kastenbauer S, Koedel U, Becker BF, Pfister HW. 2002. Oxidative stress in bacterial meningitis in humans. Neurology 58:186-191.
19. Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K. 1995. TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP1 toxicity. EMBO J 14:736-742.
20. Lai M, Gluckman P, Dragunow M, Hughes PE. 1997. Focal brain injury increases activin βA mRNA expression in hippocampal neurons. Neuroreport 8:2691-2694.
21. -delta delta C(T) method. Methods 25:402-408.
22. Michel U, Gerber J, Bunkowski S, Bruck W, Nau R, Phillips DJ. 2003. Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia. J Neurochem 86:238-245.
23. Nau R, Bruck W. 2002. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 25:38-45.
24. Ohguchi M, Yamato K, Ishihara Y, Koide M, Ueda N, Okahashi N, Noguchi T, Kizaki M, Ikeda Y, Sugino H, Nisihara T. 1998. Activin A regulates the production of mature interleukin-1β and interleukin-1 receptor antagonist in human monocytic cells. J Interferon Cytokine Res 18:491-498.
25. Robinson AP, White TM, Mason DW. 1986. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 57:239-247.
26. Rosen D, Miller SC, DeLeon E, Thompson AY, Bentz H, Mathews M, Adams S. 1994. Systemic administration of recombinant transforming growth factor β 2 (rTGF-β 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15:355-359.
27. Schubert D, Kimura H, LaCorbiere M, Vaughan J, Karr D, Fischer WH. 1990. Activin is a nerve cell survival molecule. Nature 344:868-870.
28. Tretter YP, Munz B, Hubner G, ten Bruggencate G, Werner S, Alzheimer C. 1996. Strong induction of activin expression after hippocampal lesion. Neuroreport 7:1819-1823.
29. Tretter YP, Hertel M, Munz B, ten Bruggencate G, Werner S, Alzheimer C. 2000. Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat Med 6:812-815.
30. Weightman NC, Sajith J. 2005. Incidence and outcome of pneumococcal meningitis in northern England. Eur J Clin Microbiol Infect Dis 24:542-544.
31. Yu EW, Dolter KE, Shao LE, Yu J. 1998. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin Exp Immunol 112:126-132.